Skip to main content

                        MALARIA 

Causes:

Malaria is caused by the Plasmodium parasite, which is transmitted to humans through the bite of infected female Anopheles mosquitoes. There are several species of Plasmodium that can cause malaria in humans, with Plasmodium falciparum and Plasmodium vivax being the most common and dangerous.


Transmission:

The transmission occurs when an infected mosquito bites a person and injects the parasite into the bloodstream. Additionally, malaria can also be transmitted through blood transfusions, organ transplants, or from a mother to her unborn child.


Symptoms:

Symptoms of malaria usually appear 10–15 days after the infective mosquito bite. The initial symptoms are flu-like and can include:

- Fever

- Chills

- Sweats

- Headache

- Nausea

- Muscle aches

If not treated promptly, malaria can progress and cause severe complications, including:


Effects:

- Severe anemia due to the destruction of red blood cells

- Cerebral malaria, which can lead to coma, seizures, and neurological damage

- Organ failure, particularly of the kidneys or liver

- Pulmonary edema

- Hypoglycemia

- Death


Prevention:

Preventive measures include:

- Using insecticide-treated bed nets

- Wearing protective clothing that covers the arms and legs

- Using insect repellent

- Taking antimalarial medications when traveling to areas where malaria is prevalent


Treatment:

The treatment for malaria depends on the type of parasite causing the infection, the severity of the disease, and the patient's age and health status. Commonly used antimalarial drugs include:

- Chloroquine

- Artemisinin- based combination therapies (ACTs)

- Quinine

- Mefloquine


Global Impact:

Malaria is a major global health problem, particularly in sub-Saharan Africa. According to the World Health Organization (WHO), in 2019, there were an estimated 229 million cases of malaria worldwide, resulting in approximately 409,000 deaths. Children under the age of 5 are the most vulnerable population group, accounting for more than two-thirds of all malaria deaths.


Efforts to control and eliminate malaria include:

- Vector control through mosquito nets and indoor residual spraying

- Early diagnosis and prompt treatment

- Development of new antimalarial drugs and vaccines

- Public health education and community engagement


Conclusion:

Malaria is a life-threatening disease caused by the Plasmodium parasite, transmitted through the bite of infected mosquitoes. It is a major global health problem, particularly in tropical and subtropical regions. Prevention, early diagnosis, and prompt treatment are crucial in reducing the burden of malaria and preventing complications and death.

Comments

Popular posts from this blog

Stepping Up Response to Curb Infectious Diseases in Nigeria

 Abuja - In Nigeria, vulnerable populations, especially those in underserved communities, remain at high risk of infectious diseases, including Lassa fever—an acute viral hemorrhagic illness caused by the Lassa virus. Endemic in Nigeria, Lassa fever continues to affect thousands annually, with the dry season (December–April) being the peak transmission period. In 2024, the disease has been particularly severe, with 1,059 confirmed cases reported across 28 states, resulting in 175 deaths (16.6% case fatality rate). Alarmingly, 35 healthcare workers have been infected during the outbreak, underscoring the urgent need for robust infection prevention measures. The Lassa virus is primarily transmitted to humans through exposure to food or household items contaminated with the urine or feces of infected Mastomys rats. Secondary transmission can occur through direct contact with the bodily fluids of infected individuals, posing significant risks to healthcare and laboratory workers who la...

World Health Day 2024: QNET Highlights Vital Role Of Supplements In Promoting Holistic Wellnes

As the world marks World Health Day 2024, QNET, a global leader in e-commerce-based direct selling, has taken significant steps to promote holistic wellness by introducing a range of innovative health supplements. With a steadfast commitment to enhancing lives globally, QNET works with leading health experts and utilizes cutting-edge research to unveil supplements designed to address diverse health needs and promote total well-being. In today’s world, good health and well-being are of prime importance, and the significance of dietary supplements in achieving total wellness cannot be overstated. World Health Organization statistics show that the impact of low nutrition-related diseases accounts for 73% of all deaths and 60% of the global disease burden. As individuals are increasingly seeking comprehensive solutions to bridge nutritional gaps and improve their general health, QNET emerges as a leading advocate for health equity with its range of high-quality health supplements. By focu...

According to a study, thousands of South Asian persons in the United Kingdom may receive erroneous type 2 diabetes tests.

Diabetes UK, research type 2 diabetes. New research, which will be discussed tomorrow at the Diabetes UK Professional Conference 2024, has uncovered a genetic variation that is almost unique to people of South Asian descent and impacts the accuracy of the diabetes haemoglobin A1c (HbA1c) test. This test measures the average blood sugar level during the past two to three months. It is critical for diagnosing type 2 diabetes, tracking prediabetes, and determining diabetic management. South Asians with this genetic variation may have artificially low HbA1c values, delaying the diagnosis of type 2 diabetes. Dr Miriam Samuel of Queen Mary University London and colleagues in the Genes & Health Research Team identified a genetic variant that is found in 7.6 percent of people of South Asian heritage but is rare in other ethnicities using genetic and health data from the Genes & Health study (over 60,000 individuals of Bangladeshi or Pakistani ethnicity living in England) and the UK...